Dr. Javier Bolanos Meade, MD

Dr. Meade practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Meade's NPI, 1578529277, was assigned on April 22, 2006. Dr. Meade holds Maryland license D58790.

Dr. Meade's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Meade's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Meade is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Meade to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meade practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Meade's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Meade is licensed in Maryland.

CMS data shows 452 Medicare services from Dr. Meade across 6 procedure codes in 2024, for 89 Medicare patients. Medicare paid $34,316 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Dr. Meade in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Meade's median patient age at 67, with 39% women.

In 2024, Dr. Meade wrote 287 Medicare Part D claims for 25 patients. 63% of them were for generic drugs. CMS names the drug for 184 of them, across 8 drugs with 11 or more claims each, at $1,400,869 in total drug cost. In 2023, CMS named 117 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Meade for performance year 2024, reported as part of a group. CMS lists Dr. Meade as offering telehealth.

CMS Open Payments shows 22 general payments to Dr. Meade from 3 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 73% of the total. Incyte Corporation paid the most, $10,085.